Clinical rebound after treatment with nirmatrelvir/ritonavir in COVID-19

Related articles

1. An Open-Label Feasibility Study of Remdesivir in Long COVID: Results from the ERASE LC Trial

   This article has 22 authors:

   1. Mark A Faghy
   2. Jade Chynoweth
   3. Anton Barnett
   4. Lindsay Skipper
   5. Victoria Allgar
   6. Helen Neilens
   7. Kayle-Anne Sands
   8. Amber Lord
   9. Helen Hambly
   10. Paigan J Aspinall
   11. Chris Rollinson
   12. W David Strain
   13. Rebecca Owen
   14. Callum Thomas
   15. Marie J Grigg
   16. Sascha H Kranen
   17. Kinan Mokbel
   18. Karen M Knapp
   19. Hairil Abdul Razak
   20. Ruth Ashton
   21. Ian Maidment
   22. Tom Bewick

2. Efficacy of antioxidant therapy in mild to moderate SARS-CoV-2 infection: A pilot experimental arm of the CanTreatCOVID adaptive platform trial

   This article has 24 authors:

   1. Banafshe Hosseini
   2. David Jenkins
   3. Peter Daley
   4. Kerry McBrien
   5. Srinivas Murthy
   6. Amanda Condon
   7. Bruno R. da Costa
   8. Michelle Greiver
   9. Peter Jüni
   10. Peter Selby
   11. Norman Umali
   12. Meichen Liu
   13. Haolun Shi
   14. Kawsika Sivayoganathan
   15. Darshna Patel
   16. Melanie Paquette
   17. Helen Hue My Nguyen
   18. Marc Malty
   19. Aleksandra Nedeljkovic
   20. Nerissa Situ
   21. Gabriel So
   22. Ethan Belo
   23. Yueyang Han
   24. Andrew D. Pinto

3. Quantifying the symptom burden of COVID-19: pre-infection through 1 month

   This article has 9 authors:

   1. Alon Yehoshua
   2. Laura L. Lupton
   3. Tianyan Hu
   4. Joseph C. Cappelleri
   5. Meghan B. Gavaghan
   6. Laura Puzniak
   7. Rachel Brathwaite
   8. Manuela Di Fusco
   9. Xiaowu Sun